CELLPOINT DIAGNOSTICS
CellPoint Diagnostics is an early stage company developing diagnostic, monitoring, and molecular analytical tools for cancer. Their novel, proprietary technology captures and analyzes circulating tumor cells ("CTCs") directly from patient blood. Scientific and clinical data have demonstrated that CTCs are derived from the primary tumor, and the assessment of the number of CTCs in the blood has been shown to accurately predict survival for cancer patients. Their goal is to commercialize produc... ts that will provide safe, non-invasive "blood-based biopsies" which will present physicians and patients with highly accurate, real-time, individualized clinical information on disease status and treatment response. They intend to identify, diagnose and guide treatment to the specific agents of lethal metastatic cancer. This has the potential to transform cancer from a deadly disease to a chronic, managed condition and will provide a powerful tool for the development of new cancer drugs.
CELLPOINT DIAGNOSTICS
Industry:
Developer Platform Health Care Health Diagnostics
Founded:
2006-01-01
Address:
La Jolla, California, United States
Country:
United States
Total Employee:
1+
Status:
Active
Contact:
(858)551-8700
Email Addresses:
[email protected]
Total Funding:
11.2 M USD
Similar Organizations
Biomedica Diagnostics
BioMedica Diagnostics is a medical company that focuses on providing diagnostic solutions in the global human and animal health arenas.
Cytodiagnostics
Cytodiagnostics is a biotechnology company and developing nanotechnology derived products and services for life science research.
Investors List
Mohr Davidow Ventures
Mohr Davidow Ventures investment in Series A - CellPoint Diagnostics
Northgate Capital
Northgate Capital investment in Series A - CellPoint Diagnostics